home / stock / nerv / nerv news


NERV News and Press, Minerva Neurosciences Inc From 10/17/22

Stock Information

Company Name: Minerva Neurosciences Inc
Stock Symbol: NERV
Market: NASDAQ
Website: minervaneurosciences.com

Menu

NERV NERV Quote NERV Short NERV News NERV Articles NERV Message Board
Get NERV Alerts

News, Short Squeeze, Breakout and More Instantly...

NERV - Minerva Neurosciences Receives Refusal to File Letter from FDA for its New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

BURLINGTON, Mass., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that the company has received a refusal to...

NERV - TOPS, SURG: The Top 5 Short Squeeze Stocks This Week

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: g0d4ather / Shutterstock.com Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week! Luckily, Fintel has traders covered with it...

NERV - NERV, FAZE: The Top 5 Short Squeeze Stocks This Week

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Short squeeze stocks are still worth keeping track of as traders look for potential gains this week! This has us turning to Fintel and its Short Squeeze Leaderboard for the latest stocks t...

NERV - NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Alextype/Shutterstock.com Traders continue to show interest in short squeeze stocks this week as they seek out likely targets to push higher. This has us checking out Fintel’s Short Squeeze Leaderb...

NERV - Minerva Neurosciences Announces Listing Transfer to Nasdaq Capital Market

BURLINGTON, Mass., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported a listing transfer from The Nasdaq Global ...

NERV - Hot Penny Stocks To Buy For Under $1 Right Now

Penny Stocks To Buy For Less Than A Dollar Menu Item This article looks at a few of the hottest penny stocks to buy for under $1. While that’s not anything to guarantee gains, lower-priced stocks tend to offer up stronger and faster gain potential if the stars align. After you re...

NERV - Minerva Neurosciences: Biotech On The Move

Summary NERV stock price has been on fire in recent days. Minerva Neurosciences' troubled roluperidone is just about its lone project candidate. Minerva's financial condition is fraught but adequate for the situation. Minerva Neurosciences ( NERV ) is a name I ha...

NERV - Penny Stocks To Buy Now? 3 To Watch After NERV Stock Explodes 160%

Are You Looking For Penny Stocks To Buy? It has become an almost daily occurrence that at least one stock under $5 explodes. You can go back to our catalog of articles about exploding penny stocks and see for yourself. Whether it has been one of the famous meme stocks like Bed Bath &...

NERV - Billionaire Steven Cohen Just Made a Big Bet on Minerva Neurosciences (NERV) Stock

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Minerva Neurosciences (NASDAQ: NERV ) are soaring higher by over 70%  following a purchase by Steve Cohen’s Point72 Asset Management and the company’s submission of a new drug applicati...

NERV - Minerva Neurosciences rises 75% after Steven Cohen firm discloses large stake

Minerva Neurosciences ( NASDAQ: NERV ) is up 75% in Wednesday afternoon trading following an SEC filing stating that Point72 Capital Advisors has an 8.8% stake in the company. The company reached a high today of $8.58 per share, though that is still well below the ...

Previous 10 Next 10